We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+18.89%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$15.4B
AUM Growth
+$2.85B
Cap. Flow
-$497M
Cap. Flow %
-3.23%
Top 10 Hldgs %
33.56%
Holding
340
New
31
Increased
113
Reduced
120
Closed
45

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$92.9M
2
BIDU icon
Baidu
BIDU
+$81.7M
3
META icon
Meta Platforms (Facebook)
META
+$80.7M
4
INSP icon
Inspire Medical Systems
INSP
+$67.9M
5
ON icon
ON Semiconductor
ON
+$64.8M

Top Sells

Rank Stock Value
1
ACGL icon
Arch Capital
ACGL
+$77.5M
2
MSFT icon
Microsoft
MSFT
+$66.2M
3
BDX icon
Becton Dickinson
BDX
+$63M
4
BILL icon
BILL Holdings
BILL
+$62.3M
5
PEN icon
Penumbra
PEN
+$58.1M

Sector Composition

Rank Sector Weight
1 Technology 36.04%
2 Healthcare 20.69%
3 Financials 16.5%
4 Miscellaneous 13.59%
5 Communication Services 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTES icon
251
NetEase
NTES
$75.5B
$334K ﹤0.01%
3,774
+6
+0.2% +$517
PYPL icon
252
PayPal
PYPL
$46.2B
$325K ﹤0.01%
4,276
+359
+9% +$27.6K
BEKE icon
253
KE Holdings
BEKE
$18.4B
$313K ﹤0.01%
16,602
-2,059
-11% -$38.1K
CSTL icon
254
Castle Biosciences
CSTL
$988M
$304K ﹤0.01%
13,398
TRMB icon
255
Trimble
TRMB
$13.7B
$288K ﹤0.01%
5,500
-2,500
-31% -$133K
OMCL icon
256
Omnicell
OMCL
$1.53B
$209K ﹤0.01%
3,568
-9,774
-73% -$539K
LAB icon
257
Standard BioTools
LAB
$273M
$195K ﹤0.01%
+100,000
New +$198K
STXS icon
258
Stereotaxis
STXS
$133M
$156K ﹤0.01%
76,687
ARWR icon
259
Arrowhead Research
ARWR
$11.4B
-12,547
Closed -$509K
AZTA icon
260
Azenta
AZTA
$1.4B
-5,540
Closed -$323K
BDX icon
261
Becton Dickinson
BDX
$48.4B
-247,586
Closed -$63M
BILL icon
262
BILL Holdings
BILL
$4.24B
-571,504
Closed -$62.3M
CFR icon
263
Cullen/Frost Bankers
CFR
$10.2B
-39,889
Closed -$5.33M
CMA
264
DELISTED
Comerica
CMA
-62,443
Closed -$4.17M
DDOG icon
265
Datadog
DDOG
$82.6B
-77,996
Closed -$5.73M
DE icon
266
Deere & Co
DE
$182B
-13,854
Closed -$5.94M
EFSC icon
267
Enterprise Financial Services Corp
EFSC
$2.32B
-107,318
Closed -$5.25M
ESQ icon
268
Esquire Financial Holdings
ESQ
$1.46B
-12,436
Closed -$538K
EW icon
269
Edwards Lifesciences
EW
$49.3B
-76,063
Closed -$5.68M
EWBC icon
270
East-West Bancorp
EWBC
$17.7B
-79,872
Closed -$5.26M
GMED icon
271
Globus Medical
GMED
$9.96B
-723,454
Closed -$53.7M
GTLS.PRB
272
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
-75,000
Closed -$3.8M
HCAT icon
273
Health Catalyst
HCAT
$128M
-26,640
Closed -$283K
HRMY icon
274
Harmony Biosciences
HRMY
$2.42B
-534,325
Closed -$29.4M
ITRI icon
275
Itron
ITRI
$4.02B
-63,000
Closed -$3.19M

Similar funds

Polar Capital Holdings's Q1 2023 Portfolio in Review

As of Q1 2023, Polar Capital Holdings held 340 positions worth $15.4B, up 23% from $12.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Polar Capital Holdings withdrew a net $497M in Q1 2023, closing 45 positions and reducing 120 holdings. Its most notable exit was Becton Dickinson, an estimated $63M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital Holdings opened a new position in Baidu worth $87M.

  • Polar Capital Holdings's largest Q1 2023 buy was Baidu: 576,222 shares worth $87M.
  • Polar Capital Holdings added most to Uber in Q1 2023, an estimated $92.9M increase.
  • Polar Capital Holdings's biggest Q1 2023 reduction was Arch Capital, cutting an estimated $77.5M.
  • Polar Capital Holdings fully exited Becton Dickinson in Q1 2023, selling an estimated $63M.
  • Polar Capital Holdings's ten largest holdings make up 34% of its $15.4B portfolio in Q1 2023.
  • Polar Capital Holdings opened 31 new positions and closed 45 in Q1 2023.
  • Polar Capital Holdings's portfolio value rose 23% quarter-over-quarter to $15.4B.

Based on Polar Capital Holdings's 13F filing for Q1 2023, filed 15 May 2023.